To assess the impact of albumin on different tumor stages, we divided patients into subgroups by N-stage (N0 vs. N1-4), and found hypoalbuminaemia as a worse survival factor in both N0 group (X2 = 11.078, p = 0.004) and N1-4 group (X2 = 7.236, p = 0.027). This evidence concerns the gene ALB and Hypoalbuminemia.